CP-547632, a new oral VEGFR-2 tyrosine kinase inhibitor, advances to studies in humans April 11, 2002
New antimitotic indole-oxazoline derivative exhibits antivascular and proapoptotic effects April 11, 2002
Proof of principle demonstrated for Corixa's duocarmycin/tumor-activated prodrug approach April 11, 2002
NVP-LAF-389 induces amino-terminus changes in cytosolic protein indicative of enzyme inhibition April 11, 2002
Inhibitors of VEGF useful for cancer and rheumatoid arthritis described in AstraZeneca patents April 10, 2002
RSS